Leptin is an adipocyte-secreted hormone that regulates food intake and body weight, and that was recently reported to suppress sweet sensitivity in an animal model. We investigated the associations among sweet preference, obesity, and polymorphisms of the leptin gene (LEP ) or leptin receptor gene (LEPR). A total of 3,653 residents randomly selected from among the citizens of Suita City, Osaka, Japan were enlisted as subjects, in whom we investigated sweet preference, clinical characteristics, including obesity and serum leptin level, and the polymorphisms of LEP and LEPR (G -2548A and A19G for LEP; R109K, R223Q, and rs3790439 for LEPR). We determined the associations among the parameters using logistic regression analysis, in order to consider potential confounding factors for sweet preference and/or obesity. The LEP A19G and LEPR R109K polymorphisms were associated with sweet preference, whereas the serum leptin level was not. Further, the LEPR 109KK genotype was found to be associated with obesity along with sweet prefer- 
Introduction
Obesity is a risk factor for lifestyle-related and cardiovascular diseases (1), while leptin is an adipocyte-secreted hormone that regulates food intake, energy expenditure, and body weight (2, 3) , and is well known to be related to obesity based on its ability to activate the leptin receptor (4) . There have been numerous studies examining the association between human leptin gene (LEP) or leptin receptor gene (LEPR) polymorphisms and obesity (5) (6) (7) (8) (9) (10) , with some of these studies reporting a positive correlation and some a negative correlation between the two.
Leptin has been shown to suppress sweet preference in animal models (11) , and it suppressed neural and behavioral responses to sweet substances through its action on the leptin receptor in taste bud cells of mice (12) . The mechanisms of this suppressive effect have been explained by the fact that leptin increases outward K + currents in taste bud cells via leptin receptors, leading to a reduction in excitability of the taste bud cells (13) . The neural and behavioral sensitivities to sweet stimuli have been shown to be enhanced in db/db mice, an animal model for obesity, in the presence of a mutation of the LEPR (11) .
Although it has been reported that genetic variations underlie specific eating patterns (14) and sweet preference is considered to be a risk factor for obesity, few reports have shown an association between them (15) , and none have examined whether human LEP and LEPR polymorphisms have effects on sweet preference. However, there have been several reports indicating associations between LEP/LEPR polymorphisms and obesity (5) . In the present study, we examined the associations of LEP/LEPR polymorphisms with sweet preference and attempted to determine whether these polymorphisms are associated with obesity because of their relationship to sweet preference.
Methods

Subjects
Between April 2002 and February 2004, we recruited 3,653 residents who had been participating in a public health physical checkup for citizens living in Suita City, located in the northern area of Osaka, Japan, since 1991. All subjects gave their written informed consent for the study, including genotyping. The study design was approved by the institutional review board and the ethics committee of the National Cardiovascular Center.
Measurements of Clinical Parameters
Blood pressure was determined after at least 10 min of rest in a sitting position. The final blood pressure value was the mean of 2 physician-obtained measurements (performed more than 3 min apart). Hypertension was defined as systolic blood pressure (SBP) ≥ 140 mmHg, diastolic blood pressure (DBP) ≥ 90 mmHg, or current use of antihypertensive agents. Diabetes mellitus (DM) was defined as fasting blood glucose ≥ 126 mg/dL, HbA1c ≥ 6.5%, or the current use of insulin or oral anti-diabetic agents. Hyperlipidemia was defined as total cholesterol ≥ 220 mg/dL, triglyceride ≥ 150 mg/dL, or the current use of anti-hyperlipidemia agents. Body mass index (BMI) was calculated by dividing weight (kg) by height (m) squared. For our analysis of obesity, we defined subjects in the top 25% of BMI results (above the third quartile) in each 5-year age group as obese, while those in the bottom 25% of BMI subjects were used as controls.
Semi-Quantification of Sweet Preference
A questionnaire designed to measure whether subjects had a "sweet tooth" was administered to each subject. The questionnaire consisted of a single question: "Do you like things that taste sweet?" to which the following responses were available: 1: No, I hate them; 2: No, I don't like them very much; 3: Neither yes or no; 4: Yes, I like them; and 5: Yes, I like them very much. The written answers were confirmed during an interview. To eliminate crossover, subjects who selected response number 5, above, were considered to have a sweet preference (n= 1,751) and those that selected response numbers 1, 2, or 3 were defined as controls (n= 869).
Polymorphism Study
Genomic DNA samples were collected from peripheral leukocytes using an NA-3000 (Kurabo Industries Ltd., Osaka, Japan) and initial polymorphism screening was performed using 24 DNA samples. All detected variations were further confirmed by a direct sequencing method using an ABI 3700 (Applied Biosystems, Foster City, USA). The genotypes were then determined using a TaqMan PCR system (ABI PRISM 7900HT; Applied Biosystems).
Statistical Analysis
The associations between sweet preference and obesity, the polymorphisms and sweet preference, and the polymorphisms and obesity were investigated using logistic regression analysis, with consideration of potential confounding factors (age, sex, smoking habit, drinking habit, and comorbidity of hypertension, diabetes, and hyperlipidemia). In addition, a Cochran-Armitage trend (CA) test was used to analyze the associations between the polymorphisms and sweet preference. Further, an analysis of covariance was used together with a path analysis, which is the statistical method commonly used to evaluate the relative importance of various causes (16) , to investigate whether the polymorphisms were related to obesity based on their relationship to sweet preference. All analyses were performed using Statview software (SAS Institute Inc., Cary, USA). Values of p< 0.05 were considered to be statistically significant. Table 1 shows the characteristics and frequencies of the LEP/ LEPR polymorphisms in 24 control subjects, along with the linkage disequilibrium (LD) patterns. Since the results indicated that LEPR N656K and rs3790439 had strong LD values, we further investigated rs3790439 instead of N656K. To examine the significant difference between the expected results and the raw ones in the genotype distribution, we used Hardy-Weinberg equilibrium. There were no significant differences in genotype frequencies of the polymorphisms between males and females (data not shown), which were nearly identical to the results in an Asian population reported by the National Center of Biotechnology Information (NCBI). Based on these results, we selected a total of 5 polymorphisms; G−2548A and A19G for LEP, and R109K, R223Q, and rs3790439 for LEPR.
Results
LEP/LEPR Polymorphisms
Sweet Preference and Clinical Characteristics
The distribution of answers to the sweet preference question in the questionnaire was not a normal probability distribution, and response number 5 (like sweet-tasting things very much) was chosen with the highest frequency (response 1: 5.9%; 2: 13.8%; 3: 11.6%; 4: 5.9%; 5: 62.9%). Thus we used not covariance analysis but logistic regression analysis. There was a significant difference between males and females in the choice of response number 5, as females more frequently stated their preference for a sweet taste (males: 58.6%; females: 66.6%).
The clinical characteristics of the study subjects are shown in Table 2 . When clinical characteristics were compared between the subjects with a sweet preference and the controls, the results indicated that low-density lipoprotein (LDL) cholesterol values were significantly higher in the subjects with a sweet preference and that SBP and DBP were lower in those groups (p values: LDL cholesterol, 0.016; SBP, 0.023; DBP, 0.023) (Table 2A ). In addition, the ratios for smoking and alcohol habits were significantly lower (p values: current smoker, < 0.0001; alcohol drinker, < 0.0001) and the ratio for hyperlipidemia was higher (p values, 0.027) in those with a sweet preference. Also, 
Associations of LEP and LEPR Polymorphisms with Sweet Preference and Obesity
The associations of LEP and LEPR polymorphisms with sweet preference are depicted in Table 4A and B, respectively. The results indicated that there was a significant association between the LEP A19G and LEPR R109K polymorphisms and sweet preference (LEP A19G, p= 0.032
. We also examined the associations by χ 2 tests, and the results indicated the same tendency (data not shown). Thus, subjects with LEP 19GG or LEPR 109KK tended to be subjects with a sweet preference. However, no correlation between LEP A19G and LEPR R109K was observed. In the Cochran-Armitage trend (CA) test, associations between sweet preference and LEP A19G and LEPR R109K were shown much more clearly (Fig. 1) . Those results indicated that there was a significant association between sweet preference and LEP 19GG (trend p value = 0.026) and LEPR 109KK (trend p value = 0.025). Further, the ratios of LEP 19GG and LEPR 109KK occurrence gradually increased with higher levels of sweet preference. Next, we investigated the association of LEP and LEPR polymorphisms with serum leptin levels, since some reports have noted that the LEP G−2548A and LEP A19G polymorphisms are associated with serum leptin levels. (10, (17) (18) (19) We indeed found that both LEP G−2548A (total, male, and female) and LEP A19G (total and male) were significantly associated with serum leptin levels in our subjects (data not shown). However, we concluded that LEP A19G does not affect sweet preference through its change of serum leptin levels, since no correlation was found between sweet preference and serum leptin level (data not shown). We also studied the association of these polymorphisms with obesity (Table  5) , and the results indicated that there was a strong association between the LEPR polymorphisms (R109K and R223Q) and obesity (LEPR R109K, p= 0.0076 [dominant] ; LEPR R223Q, p= 0.025 [dominant]). We also evaluated the mean value of BMI among each genotype subject, and the results showed the same tendency (data not shown). Subjects with LEPR 109KK or 223QQ tended toward obesity and the tendency with LEPR 109KK was stronger in males.
Based on our results, LEPR 109KK was considered to be associated with both sweet preference and obesity. Then, we investigated whether LEPR 109KK had an effect on obesity by means of its relationship to sweet preference. First we confirmed that there were no interactions between sweet preference and the genotypes affecting obesity. We further utilized a path analysis to consider several potential confounding factors-age, sex, smoking habit, drinking habit, and comorbidity of hypertension, diabetes or hyperlipidemia-and we used obesity as an induced variable, and both LEPR 109KK presence and sweet preference as objective variables. We found that there was a significant association of both LEPR 109KK and sweet preference with obesity, and that LEPR 109KK had an effect on obesity via its induction of sweet preference (Fig.  2) . The contribution of sweet preference to obesity was calculated to be about 2.8%, so we speculated that LEPR 109KK might also affect obesity through other means.
Discussion
In the present study, sweet preference was shown to be associated with obesity, and the LEP A19G and LEPR R109K polymorphisms were significantly associated with sweet preference. It was also revealed that LEPR 109KK had an effect on obesity via its induction of sweet preference. LEPR 223QQ was also shown to be associated with obesity but its 
Fig. 1. Distribution of answers to the sweet preference question by subjects with the LEP 19GG (A) and LEPR 109KK (B) polymorphisms. The ratios of LEP 19GG and LEPR 109KK occurrence gradually increased with increases in the degree of sweet preference, and there was a significant association between sweet preference and LEP 19GG (trend p value = 0.026) and LEPR 109KK (trend p value = 0.025).
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association was found to be weaker than that of LEPR 109KK. It has been reported that sweeteners activate transduction cascades in sweet-responsive cells, with one involving cAMP and the other involving inositol trisphosphate (IP3) in taste bud cells (20) . Sugar increases intracellular cAMP, which activates protein kinase A (PKA) and closes K + channels mediated by phosphorylation, which in turn leads to influx of Ca 2+ through voltage-gated Ca 2+ channels. In contrast, artificial sweeteners such as saccharin elevate IP3 levels, which induces Ca 2+ release from intracellular stores and an elevation of intracellular Ca 2+ concentration. The IP3 pathway is proposed to result in closure of K + channels via protein kinase C (PKC)-mediated phosphorylation activated by concomitantly produced diacylglycerol (DAG) (21) . Therefore, both second messenger pathways may converge on the same K + channels in taste bud cells. The recent studies (11, 13) noted that leptin increased the K + conductance of taste cells, leading to hyperpolarization and reduction of cell excitability, and leptin suppressed behavioral responses to sweet substances. Thus we considered that the LEPR R109K or the LEP A19G polymorphism might affect the molecular mechanisms of leptin activation of K + currents like the currents in pancreatic β cells (22) and hypothalamic neurons (23) .
The LEPR R109K polymorphism is located in exon 4 of the gene, and changes an arginine to a lysine. LEPR R109K is not located in the intracellular domain, which is essential for the JAK-STAT signal transduction pathway (24, 25) of this peptide, nor in the leptin-binding site (26) . The functional relevance of the polymorphism has not been clarified, though previous reports have found that it is associated with obesity, including in Asians (8) . Thus, our results may provide useful information for the treatment and prevention of obesity, while they also suggest a new biological pathway for the role of LEPR R109K in sweet preference, which might induce obesity. In addition, our findings may inform future clinical attempts to apply genetic information to the treatment of obesity, though additional investigations are needed.
Another intriguing polymorphism, LEP A19G, is located in the 5′ untranslated region (5′-UTR) of the LEP gene. It was previously reported that obese individuals with the A19 allele had significantly higher leptin concentrations as compared to subjects with 19GG (19) , which is supported by our results. Although both the LEP G −2548A and A19G polymorphisms are associated with serum leptin levels, only A19G had a significant association with sweet preference. Since the rs1349419 polymorphism in the 5′-flanking region of LEP is considered to modify transcription factor-binding sites (13, 24) , it is intriguing that A19G showed a strong LD with rs1349419. Thus, it could be possible that A19G has an effect on sweet preference through functional changes of the rs1349419 polymorphism. In addition, the LEPR R109K polymorphism might also influence conformational changes of LEPR, thus affecting sweet preference, as it has been reported that the leptin receptor exists as a multimeric complex and leptin activates the receptor by inducing a conformational change (26) .
In clinical practice, obesity is closely associated with increased morbidity and mortality caused by cardiovascular diseases, diabetes, and hypertension (1, (27) (28) (29) (30) . Therefore, obese patients should be given dietary instruction, though many with obesity or lifestyle-related diseases are dissatisfied when sweets are restricted. Our results indicate that individuals with the LEPR 109KK allele tend to prefer sweets naturally, and therefore dietary therapy for those individuals may have to be well thought out. We consider that our data regarding the LEPR R109K polymorphism could lead to its use as a marker for personalized medical intervention when treating obesity and lifestyle-related diseases. Additionally, in this study, there was a gender difference in the distribution of answers in regard to sweet preference and the association between the polymorphisms and sweet preference. However, it was difficult to accurately determine the reason for this gender difference, because sweet preference is also influenced by various unquantifiable factors, such as cultures and customs.
In conclusion, we found associations among sweet preference, obesity and LEPR polymorphisms. Further, the role of LEPR R109K in sweet preference in the present subjects was found to be a possible cause of obesity. This is the first report showing a gene for sweet preference in humans, and we consider that our findings will contribute to better treatment of obesity and lifestyle-related diseases. 
